<i>In vitro</i> antifungal activity of pelgipeptins against human pathogenic fungi and <i>Candida albicans</i> biofilms
Systemic mycoses have become a major cause of morbidity and mortality, particularly among immunocompromised hosts and long-term hospitalized patients. Conventional antifungal agents are limited because of not only their costs and toxicity but also the rise of resistant strains. Lipopeptides from <...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2021-01-01
|
Series: | AIMS Microbiology |
Subjects: | |
Online Access: | http://www.aimspress.com/article/doi/10.3934/microbiol.2021003?viewType=HTML |